bioAffinity Technologies (BIAF) Depreciation & Amortization (CF) (2021 - 2026)
bioAffinity Technologies (BIAF) reported Depreciation & Amortization (CF) of $114518.0 for Q1 2026, down 25.92% year-over-year from $154588.0 in Q1 2025, and down 7.39% quarter-over-quarter from $123659.0 in Q4 2025.
bioAffinity Technologies (BIAF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $114518.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $114518.0, down 25.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $464766.0 (down 23.88% YoY), and the FY2025 annual result was $504836.0, down 16.64% from the prior year.
- Depreciation & Amortization (CF) retreated to $114518.0 in Q1 2026 per BIAF's latest filing, from $123659.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $154588.0 in Q1 2025 and troughed at $773.0 in Q3 2022.
- A 5-year average of $87339.1 and a median of $113360.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) soared 7347.48% in 2023, then decreased 25.92% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $7330.0 in 2022, then surged by 1929.84% to $148787.0 in 2023, then increased by 3.26% to $153632.0 in 2024, then retreated by 19.51% to $123659.0 in 2025, then dropped by 7.39% to $114518.0 in 2026.
- Business Quant data shows BIAF's Depreciation & Amortization (CF) at $114518.0 in Q1 2026, $123659.0 in Q4 2025, and $113360.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 36.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 306.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 193.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 37.68 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 67.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 288.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 14.52 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 51.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 13.16 Mn |
| 10 | bioAffinity Technologies | 2.04 Mn | -1.06 Mn | - | 114,518.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114,518.00 |
| Mar 31, 2026 | 114,518.00 |
| Dec 31, 2025 | 123,659.00 |
| Dec 31, 2025 | 123,659.00 |
| Sep 30, 2025 | 113,360.00 |
| Sep 30, 2025 | 113,360.00 |
| Jun 30, 2025 | 113,229.00 |
| Jun 30, 2025 | 113,229.00 |
| Mar 31, 2025 | 154,588.00 |
| Mar 31, 2025 | 154,588.00 |
| Dec 31, 2024 | 153,632.00 |
| Dec 31, 2024 | 153,632.00 |
| Sep 30, 2024 | 151,298.00 |
| Sep 30, 2024 | 151,298.00 |
| Jun 30, 2024 | 151,070.00 |
| Jun 30, 2024 | 151,070.00 |
| Mar 31, 2024 | 149,637.00 |
| Mar 31, 2024 | 149,637.00 |
| Dec 31, 2023 | 148,787.00 |
| Dec 31, 2023 | 148,787.00 |